DoW Arthritis Translational Research Award
Funding Opportunity Number: HT942526ATRPTRA
About the opportunity
The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research relevant to Service Members, Veterans, their Families, and the American public. Research addressing any and all types of arthritis is encouraged.
Distinctive features
The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research is not allowed. A key aspect of this award is impact: the application should explicitly state how the proposed research outcomes will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions. Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.
Eligibility
Unrestricted (i.e., open to any type of entity), subject to any clarification in the text field entitled "Additional Information on Eligibility."
Funding details
- Expected number of awards: 2
- Estimated total program funding: $1,600,000
- Assistance listings: 12.420 -- Military Medical Research and Development
- Cost sharing or matching requirement: No
Key dates
- Posted date: May 01, 2026
- Last updated date: May 01, 2026
- Current closing date for applications: Oct 22, 2026
- Archive date: Nov 21, 2026
Contact information
For assistance, contact:
- eBRAP Help Desk – Phone: 301-682-5507, Email: help@eBRAP.org
- CDMRP Help Desk